JO2498B1 - PROCESS FOR PREPARING (3-OXO-2,3-DIHYDRO-1 H-isondol-1-yl) actylguanidine derivatives - Google Patents

PROCESS FOR PREPARING (3-OXO-2,3-DIHYDRO-1 H-isondol-1-yl) actylguanidine derivatives

Info

Publication number
JO2498B1
JO2498B1 JO2004155A JOP20040155A JO2498B1 JO 2498 B1 JO2498 B1 JO 2498B1 JO 2004155 A JO2004155 A JO 2004155A JO P20040155 A JOP20040155 A JO P20040155A JO 2498 B1 JO2498 B1 JO 2498B1
Authority
JO
Jordan
Prior art keywords
derivatives
dihydro
oxo
preparing
actylguanidine
Prior art date
Application number
JO2004155A
Other languages
Arabic (ar)
Inventor
سكوبرت جيرت
ريكي زاب جورج
كيل جوهانس
وارنر كليمان هاينز
هانا ريدا
جيو هوانج باو
يو زياو-دونج
جيورود يفس
Original Assignee
سانوفي - افانتيسي دويتشلاند جي ام بي اتش
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by سانوفي - افانتيسي دويتشلاند جي ام بي اتش filed Critical سانوفي - افانتيسي دويتشلاند جي ام بي اتش
Application granted granted Critical
Publication of JO2498B1 publication Critical patent/JO2498B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention relates to processes for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives of the formula I via 3-hydroxy-2,3-dihydro-1 H-isoindol-1-one derivatives or 3-(2-carbamoylphenyl). acrylic ester derivatives as intermediates, to a process for optical resolution, and to intermediates of the process according to the invention.
JO2004155A 2003-12-02 2004-11-04 PROCESS FOR PREPARING (3-OXO-2,3-DIHYDRO-1 H-isondol-1-yl) actylguanidine derivatives JO2498B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10356717A DE10356717A1 (en) 2003-12-02 2003-12-02 Process for the preparation of (3-oxo-2,3-dihydro-1H-isoindol-1-yl) -acetylguanidine derivatives

Publications (1)

Publication Number Publication Date
JO2498B1 true JO2498B1 (en) 2009-10-05

Family

ID=34638338

Family Applications (1)

Application Number Title Priority Date Filing Date
JO2004155A JO2498B1 (en) 2003-12-02 2004-11-04 PROCESS FOR PREPARING (3-OXO-2,3-DIHYDRO-1 H-isondol-1-yl) actylguanidine derivatives

Country Status (38)

Country Link
EP (1) EP1692105B1 (en)
JP (1) JP4809774B2 (en)
KR (1) KR101202604B1 (en)
CN (1) CN100526297C (en)
AR (1) AR046733A1 (en)
AT (1) ATE395334T1 (en)
AU (1) AU2004295056B2 (en)
BR (1) BRPI0417147A (en)
CA (1) CA2548020C (en)
CR (1) CR8376A (en)
CY (1) CY1108187T1 (en)
DE (2) DE10356717A1 (en)
DK (1) DK1692105T3 (en)
EC (1) ECSP066597A (en)
EG (1) EG25498A (en)
ES (1) ES2304634T3 (en)
HK (1) HK1097525A1 (en)
HR (1) HRP20080253T3 (en)
IL (1) IL175834A (en)
JO (1) JO2498B1 (en)
MA (1) MA28220A1 (en)
MY (1) MY136467A (en)
NO (1) NO20063058L (en)
NZ (1) NZ547625A (en)
OA (1) OA13293A (en)
PA (1) PA8618701A1 (en)
PE (1) PE20051037A1 (en)
PL (1) PL1692105T3 (en)
PT (1) PT1692105E (en)
RS (1) RS50571B (en)
RU (1) RU2397159C2 (en)
SI (1) SI1692105T1 (en)
TN (1) TNSN06167A1 (en)
TW (1) TWI334348B (en)
UA (1) UA83883C2 (en)
UY (1) UY28648A1 (en)
WO (1) WO2005054195A1 (en)
ZA (1) ZA200603338B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
CA2725230C (en) * 2008-04-16 2016-05-17 Kissei Pharmaceutical Co., Ltd. Hemifumarate of a pyrazole derivative
RU2518740C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE
CN107778238B (en) * 2016-08-29 2022-07-22 中山大学 Novel synthesis method of 3, 4-dihydroisoquinoline-1-ketone
CN107286074B (en) * 2017-08-16 2019-08-20 厦门华厦学院 3- hydroxyl iso-indoles -1- ketone derivatives and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
DE19737224A1 (en) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmaceutical preparation for cardiovascular treatment
DE19832429A1 (en) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction
EP1767525A1 (en) 2001-04-09 2007-03-28 Novartis Vaccines and Diagnostics, Inc. Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME

Also Published As

Publication number Publication date
ES2304634T3 (en) 2008-10-16
UA83883C2 (en) 2008-08-26
EP1692105A1 (en) 2006-08-23
BRPI0417147A (en) 2007-03-06
ZA200603338B (en) 2007-06-27
ATE395334T1 (en) 2008-05-15
PT1692105E (en) 2008-07-04
JP4809774B2 (en) 2011-11-09
NO20063058L (en) 2006-06-30
CA2548020C (en) 2013-01-08
DE10356717A1 (en) 2005-07-07
MY136467A (en) 2008-10-31
IL175834A0 (en) 2006-10-05
UY28648A1 (en) 2005-06-30
RU2006123410A (en) 2008-01-10
CA2548020A1 (en) 2005-06-16
RU2397159C2 (en) 2010-08-20
TWI334348B (en) 2010-12-11
EP1692105B1 (en) 2008-05-14
KR101202604B1 (en) 2012-11-19
SI1692105T1 (en) 2008-08-31
HRP20080253T3 (en) 2008-09-30
MA28220A1 (en) 2006-10-02
AU2004295056B2 (en) 2011-04-14
TW200526207A (en) 2005-08-16
CN100526297C (en) 2009-08-12
ECSP066597A (en) 2006-10-25
EG25498A (en) 2012-01-22
PL1692105T3 (en) 2008-09-30
DE502004007177D1 (en) 2008-06-26
KR20060111558A (en) 2006-10-27
IL175834A (en) 2010-12-30
AR046733A1 (en) 2005-12-21
WO2005054195A1 (en) 2005-06-16
PA8618701A1 (en) 2006-07-03
CY1108187T1 (en) 2014-02-12
CR8376A (en) 2007-12-04
OA13293A (en) 2007-01-31
CN1886374A (en) 2006-12-27
RS50571B (en) 2010-05-07
JP2007516243A (en) 2007-06-21
NZ547625A (en) 2010-01-29
TNSN06167A1 (en) 2007-11-15
DK1692105T3 (en) 2008-08-25
HK1097525A1 (en) 2007-06-29
PE20051037A1 (en) 2005-12-29
AU2004295056A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
DE50312946D1 (en) DIFLUORMETHYL THIAZOLYL CARBOXANILIDE
YU49003A (en) Novel process for the synthesis of 5-(4-fluorophenyl)-1/2- ((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl/-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic phenylamide
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
SG10201811715YA (en) Intermediates and methods for the synthesis of halichondrin b analogs
TW200626580A (en) Synthesis of (5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
NO20062936L (en) Process for the preparation of N-alkyl-2 (hydroxy-4-benzoyl) -3-benzofurans and its intermediates
HUP0200092A2 (en) Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same
TNSN06167A1 (en) Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives
RS8604A (en) Process for the production of beraprost and its salts
EE04642B1 (en) Method for the synthesis of (1H) benzo [c] quinolizin-3-one derivatives
TW200508392A (en) Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
GB9909229D0 (en) Enantiomers of mercapto lactones and processes for their synthesis
MXPA04003085A (en) Stereospecific process for the synthesis of 2-yl chroman derivatives.
ATE252566T1 (en) PRODUCTION OF 2-(2-ARYLMORPHOLINE-2-YL)ETHANOL DERIVATIVES AND INTERMEDIATE PRODUCTS
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
DOP2004001041A (en) PROCEDURE TO PREPARE DERIVATIVES OF (3-OXO-2, 3-DIHIDRO-1H-ISOINDOL-1-IL) - ACETILGUANIDINE
HUP0004943A2 (en) Method for preparing optionally substituted benzofuranones
AU4757000A (en) Method of producing methoxyimino acetic amide
HN2004000495A (en) PROCEDURE TO PREPARE DERIVATIVES OF (3-2,3-DIHIDRO-1H-ISOINDOL-1-IL) - ACETILGUANIDINE
TW200745012A (en) Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds
HUP0401918A2 (en) Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455
NO20026201D0 (en) Process for preparing 4-bromo-aniline derivatives
TW200724523A (en) The manufacturing method of prostaglandin F derivatives and the novel intermediates thereof